These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 985554)

  • 81. Regioelectronic factors in metabolic hydroxylation of aliphatic carbon atoms.
    Testa B; Bünzli JC; Purcell WP
    J Theor Biol; 1978 Feb; 70(4):339-44. PubMed ID: 633925
    [No Abstract]   [Full Text] [Related]  

  • 82. [On the chemistry of chlorophyll and hemin].
    Inhoffen HH
    Naturwissenschaften; 1968 Oct; 55(10):457-62. PubMed ID: 5725579
    [No Abstract]   [Full Text] [Related]  

  • 83. Isomer identification by metastable decay rates of laser-produced ions.
    Kinsel GR; Johnston MV
    Anal Chem; 1988 Oct; 60(19):2084-9. PubMed ID: 3239789
    [No Abstract]   [Full Text] [Related]  

  • 84. Models for cytochrome P-450 under physiological condition.
    Chem Pharm Bull (Tokyo); 1976 Jul; 24(7):1686-8. PubMed ID: 10089
    [No Abstract]   [Full Text] [Related]  

  • 85. The meso-hydroxylation and meso-benzoxylation of pyridine octaethylhaemochrome.
    Bonnett R; Dimsdale MJ
    Tetrahedron Lett; 1968 Feb; 6():731-3. PubMed ID: 5640099
    [No Abstract]   [Full Text] [Related]  

  • 86. A model system of cytochrome P-450: hydroxylation of aniline by iron- or hemin-thiol compound systems.
    Sakurai H; Ogawa S
    Chem Pharm Bull (Tokyo); 1979 Sep; 27(9):2171-6. PubMed ID: 519812
    [No Abstract]   [Full Text] [Related]  

  • 87. A model of cytochrome P-450; optical and EPR properties of a thiol-containing peptide-hemin system and its activity of aniline hydroxylation.
    Sakurai H; Shimomura S; Fukuzawa K; Ishizu K
    Chem Pharm Bull (Tokyo); 1978 May; 26(5):1348-52. PubMed ID: 208787
    [No Abstract]   [Full Text] [Related]  

  • 88. Aromatic methyl migration by iron-thiol and hemin-thiol systems.
    Sakurai H; Kito M
    Biochem Pharmacol; 1975 Sep; 24(17):1647-50. PubMed ID: 1191324
    [No Abstract]   [Full Text] [Related]  

  • 89. Aromatic methyl group migration and hydroxylation of p-toluidine by iron-thiol and hemin-thiol systems as a model of cytochrome P-450.
    Sakurai H; Kito M
    Chem Pharm Bull (Tokyo); 1977 Sep; 25(9):2330-5. PubMed ID: 589727
    [No Abstract]   [Full Text] [Related]  

  • 90. Hematin therapy for the porphyric attack.
    Pierach CA
    Semin Liver Dis; 1982 May; 2(2):125-31. PubMed ID: 6753162
    [No Abstract]   [Full Text] [Related]  

  • 91. Aspects of application of cytochrome P-450 and related systems in substrate hydroxylation.
    Mohr P; Scheller F; Renneberg R; Kühn M; Scheler W
    Pharmazie; 1978 Jul; 33(7):415-8. PubMed ID: 31630
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Models and mechanisms of O-O bond activation by cytochrome P450. A critical assessment of the potential role of multiple active intermediates in oxidative catalysis.
    Hlavica P
    Eur J Biochem; 2004 Nov; 271(22):4335-60. PubMed ID: 15560776
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Polarity in aromatic hydroxylation by hemin-thiol model systems for cytochrome P-450.
    Sakurai H; Kito M
    Biochem Pharmacol; 1976 Sep; 25(18):2113-6. PubMed ID: 985554
    [No Abstract]   [Full Text] [Related]  

  • 94.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 95.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 96.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.